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Abstract
Phenotypic heterogeneity in a clonal cell population is a well-observed but poorly understood phenomenon. Here, a single-
cell approach is employed to investigate non-mutative causes of phenotypic heterogeneity during the differentiation of
3T3-L1 cells into fat cells. Using coherent anti-Stokes Raman scattering microscopy and flow cytometry, adipogenic gene
expression, insulin signaling, and glucose import are visualized simultaneously with lipid droplet accumulation in single
cells. Expression of adipogenic genes PPARc, C/EBPa, aP2, LP2 suggests a commitment to fat cell differentiation in all cells.
However, the lack of lipid droplet in many differentiating cells suggests adipogenic gene expression is insufficient for lipid
droplet formation. Instead, cell-to-cell variability in lipid droplet formation is dependent on the cascade responses of an
insulin signaling pathway which includes insulin sensitivity, kinase activity, glucose import, expression of an insulin
degradation enzyme, and insulin degradation rate. Increased and prolonged insulin stimulation promotes lipid droplet
accumulation in all differentiating cells. Single-cell profiling reveals the kinetics of an insulin signaling cascade as the origin
of phenotypic variability in drug-inducible adipogenesis.
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Introduction
Targeting adipose tissues to reduce adipose mass has been
proposed as a viable approach to obesity treatment [1–3].
However, variability in adipogenesis activity among preadipocytes
presents significant challenges to drug intervention [4]. Cells with
distinct molecular profile display distinct phenotypic behavior and
drug response [5,6]. To improve the efficacy of drug treatment,
the source of cell-to-cell variability should be identified and
targeted [7]. Unlike genetic mutation which can be identified with
sequencing, non-genetic cause of cell-to-cell variability cannot be
readily investigated. Standard population measurement techniques
describe average behavior and are insufficient to investigate
variability among cells [8]. To describe the molecular cause of
phenotypic variability, cellular events and phenotypic expression
must be measured simultaneously at the level of single cells [9,10].
Such requirement demands multiple signals to be analyzed at the
same time within a single cell.
There exist a number of powerful techniques for single-cell
analysis including microscope-based cytometry [11] and flow
cytometry [12]. Traditionally, these techniques analyze the
expression of fluorescent molecules. However, technical challenges
associated with exogenous fluorescent labeling combined with
limited endogenous fluorescent molecules place a constraint on the
number of assayable molecules within a single cell. More recently,
coherent anti-Stokes Raman scattering (CARS) microscopy with
its label-free imaging capability has expanded the number of
biomolecular structures which can be optically examined [13,14].
Being highly sensitive to CH2 vibration of lipid-rich molecules,
CARS microscopy has been applied to image lipid domains,
axonal myelin sheaths, lipid-rich foam cells, and lipid-rich
metastatic cancer cells [15–18]. CARS imaging has also been
applied to study adipogenesis and lipid droplets lipolysis in 3T3-L1
cells [1,19], lipid droplets trafficking in adrenal cortical Y-1 cells
[20], and lipid storage in Caenorhabditis elegans [21]. Microfluidic
CARS flow cytometry further enables label-free high throughput
analysis of lipid droplets of mature adipocytes [22]. A unique
advantage of a CARS microscope is its capability for multimodal
nonlinear optical imaging on a single platform including CARS
and two-photon excitation fluorescence (TPEF) [23]. Combining
fluorescent imaging with vibrational imaging, a typical CARS
microscope is capable of monitoring multiple signals simulta-
neously. This capability renders CARS microscopy an ideal tool to
study the molecular cause of cell-to-cell phenotypic variability.
To study adipogenesis, a well-established cell culture model
using 3T3-L1 cell line has been employed since 1974 [24].
Adipogenesis in 3T3-L1 cells are initiated with a mixture of
adipogenic stimulants isobutylmethylxanthine (IBMX) and dexa-
methasone which turn on transcription factor PPARc to direct the
transcription of lipid synthesis genes. Then, insulin is added to
facilitate glucose uptake and promote adipocyte differentiation
(Fig. 1A) [25]. Because adipogenesis in 3T3-L1 cells has been
well-characterized, it is commonly used to study the effects of
drugs on fat cell differentiation [2]. However, heterogeneity in the
rates of lipid droplet formation among cells prevents direct
evaluation of the drug efficacy [4]. Heterogeneity in adipogenesis
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5189was first described by Green and Kehinde in 1974 in their original
3T3-L1 cell cultures and became a well-documented phenomenon
since then (Fig. S1) [24]. Using 3T3-L1 cell cultures, the
molecular controls of adipogenesis pathway have been well-
elucidated [3]. Nonetheless, the molecular cause of cell-to-cell
variability during adipogenesis remains a mystery.
Taking advantage of the multimodality of a typical CARS
microscope, we investigate the cause of cell-to-cell variability
during adipogenesis by imaging multiple cellular events simulta-
neously within single 3T3-L1 cells. Imaging data are further
complemented by high-throughput quantitative single-cell analysis
by flow cytometry. We treat each 3T3-L1 cell as a single
computing unit by defining input signals as adipogenic stimulants
IBMX, dexamethasone, and insulin. Signal processing is defined
as expression of adipogenic genes, insulin signaling, or glucose
import. And output signal is defined as the rate of lipid droplet
formation as determined by the quantity and size of cytoplasmic
lipid droplets (Fig. 1B). By keeping input signals constant, we
simultaneously measure signal processing and output signals
within single cells. Correlating signal processing to variations in
output signal would allow identification of cellular events which
are responsible for phenotypic variability among 3T3-L1 cells in
drug-inducible adipogenesis.
Results
Monitoring adipogenesis with CARS imaging, real-time
PCR, and flow cytometry
Adipogenesis in 3T3-L1 cells can be measured using a number
of techniques including CARS microscopy [1,19], adipogenic gene
expression profiling [3], and flow cytometry [4]. Using CARS
microscopy, adipogenesis is monitored by the quantity of lipid
droplets accumulation within the cell membrane (Fig. 2A). As
CARS signal arises from CH2 vibration, lipid-rich structures such
as cell membrane or lipid droplets yield positive contrast, whereas
lipid-poor structures such as cell nuclei yield negative contrast. By
integrating all positive contrasts within the cell membrane, the
total lipid accumulation within a single cell can be inferred. Using
CARS imaging, advanced-stage cells and early-stage differentiat-
ing cells can be defined as cells having high and low intracellular
lipid accumulation, respectively. The degree of fat cell differen-
tiation can also be measured by the expression level of lipid
synthesis proteins or their controlling transcription factors
(Fig. 2B) [3]. Among such proteins, increased expression of
transcription factor PPARc and its downstream target aP2 are
required for adipogenesis [3]. Conversely, reduced expression of a
membrane-bound surface protein, Pref-1, during adipogenesis is
also observed (Fig. 2B) [26]. Alternatively, flow cytometry
provides a high through-put means to assay lipid droplet formation
(Fig. 2C). By measuring side-scatter signals emanating from
passing cells, the degree of cytoplasmic granularity or size of lipid
droplets of single cells can be obtained. Indeed, flow cytometry has
been successfully used to sort 3T3-L1 cells based on the size of
their cytoplasmic lipid droplets (Fig. S2) [4].
Increased adipogenic genes expression does not
necessitate lipid droplet formation
To determine whether IBMX and dexamethasone input signals
processing is the source of variability in adipogenesis, we
simultaneously examined adipogenic genes expression and lipid
droplet formation within single 3T3-L1 cells. To monitor real-time
gene expression in single cells, we stably transfected 3T3-L1 cells
with a dual-reporter plasmid where the expression of destabilized
variants of green fluorescent protein (dsGFP) and red fluorescent
protein (dsRFP) are controlled by a PPARc and a Pref-1
promoter, respectively (Fig. 3A) [27,28]. Both dsGFP and dsRFP
were tagged with ubiquitin destruction signals such that their half-
lives were shortened to approximately 2 hours [29]. The rapid
turnover rate of fluorescent proteins mimicked that of mRNA
Figure 1. A simplified view of a drug-inducible adipogenesis system. (A) The effects of adipogenic stimulants on adipogenesis. IBMX and
dexamethasone induce expression of lipid synthesis enzymes. Insulin activates kinase signaling pathway leading to glucose import. A product of
glycolysis, acetyl CoA, serves as a substrate for lipid synthesis enzymes. Akt kinase activates expression of insulin degradation enzyme (IDE) which
allows recycling of surface insulin receptor. (B) 3T3-L1 cells as single computing units. Inputs are defined as IBMX/dexamethasone, insulin, and
glucose. Signal processing is defined as cellular activities induced by input signals which include adipogenic gene expression, insulin signaling, and
insulin-stimulated glucose import. Output is defined as intracellular lipid droplets formation.
doi:10.1371/journal.pone.0005189.g001
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promoter activity. PPARc is a nuclear factor required for gene
transcription of many lipid synthesis enzymes. Increased expres-
sion of PPARc gene has previously been shown to be sine qua non
for adipogenesis [3]. Conversely, Pref-1 is a surface membrane
bound protein whose down-regulation is required for adipogenesis
[26]. Simultaneous measurement of PPARc and Pref-1 promoter
activity serves as a self-calibrated indicator of adipogenic genes
expression.
Using TPEF to image PPARc and Pref-1 promoter activity and
CARS to image intracellular lipid droplets, we observed increased
adipogenic gene activity did not always correlate with lipid droplet
accumulation. Following IBMX and dexamethasone stimulation,
a significant increase in PPARc gene activity and a strong
suppression of Pref-1gene activity were observed in lipid-rich 3T3-
L1 cells (Fig. 3A). However, increased PPARc gene activity was
also observed in lipid-poor 3T3-L1 cells (Fig. 3A). Increased
PPARc gene activity was confirmed with real-time PCR profiling
of PPARc gene transcripts of lipid-rich and lipid-poor 3T3-L1 cell
populations sorted with flow cytometry (Fig. 3B). Expression of a
PPARc downstream target gene aP2 further indicates an increase
in PPARc protein function in both lipid-rich and lipid-poor cells
(Fig. 3B). More convincingly, early-stage marker genes including
PPARc and C/EBPa and late-stage marker genes including aP2
and LP2 were fully expressed in all cells which suggest
commitments to fat cell differentiation in both lipid-rich and
Figure 2. Monitoring adipogenesis with CARS microscopy, real-time PCR, and flow cytometry. (A) CARS visualization of intracellular lipid
droplets accumulation as a function of time after adipogenesis induction. For CARS imaging, increased lipid droplet accumulation is due to increased
of lipid amount in each cell. (B) Real-time PCR gene expression profiling of adipogenic gene markers as a function of time after adipogenesis
induction. Adipogenic gene expression levels were corrected with expression level of a house-keeping gene acidic ribosomal phosphoprotein and
normalized to 1 with the highest expression level. Error bars represent distribution across four repeated experiments. (C) Flow cytometry analysis of
side scattering signal (SSC) which indicates cytoplasmic granularity caused by lipid droplets accumulation and forward scattering signal which
indicates cell size.
doi:10.1371/journal.pone.0005189.g002
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between PPARc protein activity and lipid droplet accumulation by
adding to the differentiating cell cultures a PPARc agonist,
rosiglitazone [30]. We observed rosiglitazone addition increases
the amount of lipid droplets in lipid-rich cells (Fig. S3). However,
rosiglitazone addition had no impact on the percentage of 3T3-L1
cells with cytoplasmic lipid droplets (Fig. S3). This observation
suggests that neither increased adipogenic gene expression nor
increased PPARc protein activity necessitate lipid droplet
accumulation.
Increased insulin degradation rates in lipid-rich cells
Next, we examined the correlation between insulin signal
processing and variability in lipid droplet accumulation of 3T3-L1
cells. We used fluorescently-labeled insulin which had been widely
used with no reported perturbation to its intended function [31].
At two days after insulin stimulation, we observed lipid
accumulation in many 3T3-L1 cells (Fig. 4A). Whereas no insulin
fluorescent signal was detected in lipid-rich cells, significant insulin
fluorescent signals were observed in lipid-poor cells (Fig. 4A–D).
This observation was striking given the effect of insulin-induced
lipid droplet accumulation was evident in lipid-rich cells. Because
insulin was quickly degraded after cellular uptake [32], we
hypothesized that lipid-rich cells degrade insulin at a faster rate
than lipid-poor cells. To test this hypothesis, we first stimulated
cells with unlabeled insulin for two days, then added labeled
insulin. After 5 minutes, all lipid-rich cells quickly exhibited
labeled insulin (Fig. 4E–H); whereas, lipid-poor cells remained
resistant to the new source of labeled insulin (Fig. 4E). The
inability of lipid-poor cells to uptake new source of labeled insulin
can be attributed to competitive binding between unlabeled and
labeled insulin (Fig. S4). The continued presence of previous
source of unlabeled insulin in lipid-poor cells prevented further
uptake of new source of labeled insulin (Fig. 4B, E).
Tracking of labeled insulin in 3T3-L1 cells over time revealed
the relationship between insulin degradation and lipid droplet
accumulation. To compare insulin degradation rates between
lipid-rich and lipid-poor cells, we used a cell culture at 6 days after
adipogenesis initiation. At this time, insulin source from culture
media had been removed for 2 days; hence, no insulin should
remain in lipid-rich or lipid-poor cells. We added labeled insulin
and monitor insulin signal over time. At 5 minutes after addition,
we found insulin signals in both lipid-rich and lipid-poor cells
(Fig. 5A). In lipid-rich cells, the rate of insulin signal degradation
was more rapid in cells with high lipid accumulation than in cells
with low lipid accumulation (Fig. 5B). At 6 hours after addition,
insulin signal degraded to nearly undetectable level in lipid-rich
cells (Fig. 5C). This observation clearly supports our hypothesis of
fast insulin degradation rate in lipid-rich cells (Fig. 4A).
We further quantitatively analyzed the degradation rates of
insulin in cells at various days after adipogenesis induction. First,
we defined a number of criteria for this quantitative analysis of
insulin degradation rates. Cells stimulated with IBMX/Dex
stimulants from day 0 to day 2 were treated with 10 mg/ml
labeled insulin from day 2 to day 4. To analyze insulin degradation
rate, labeled insulin was removed on day 4. Then, cells were
exposed to 10 mg/ml of new labeled insulin source for 5 minutes
on specified days. Next, cells were washed thoroughly to remove
Figure 3. Increased adipogenic gene expression in both lipid-rich and lipid-poor cells. (A) Real-time visualization of PPARc (upper panels,
green) and Pref-1 (lower panels, red) gene activity using TPEF imaging of dsGFP (green) and dsRFP (red) signals at day 0 and day 8 after adipogenesis
induction. Intracellular lipid droplets are visualized with CARS (grey) imaging. Arrows point to representative lipid-poor cells. Scale bar: 25 mm. (B)
Real-time PCR gene expressions profiling of PPARc, aP2, and Pref-1 gene activity (upper panel), and C/EBPa and LP2 gene activity (lower panel).
PPARc and C/BEPa are transcription factors whose expressions are critical for early-stage differentiation of 3T3-L1 cells. aP2 and LP2 are lipid-binding
proteins whose expression are controlled by PPARc. aP2 and LP2 expressions mark late-stage differentiation of 3T3-L1 cells. Pref-1 is a preadipocyte
marker protein whose down-regulation is required for adipogenesis. 8lr and 8lp represent sorted lipid-rich and lipid-poor populations at day 8 after
adipogenesis induction, respectively. Error bars represent distribution across 4 repeated experiments.
doi:10.1371/journal.pone.0005189.g003
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presence of internalized labeled insulin. We defined representative
lipid-rich cells in cell cultures at 4, 6, and 8 days after adipogenesis
induction as cells having lipid droplets of approximately 2 mm,
4 mm, and 6 mm in diameters, respectively. Lipid-poor cells were
defined as cells devoid of observable lipid droplets in all time
points. These criteria allowed comparison of insulin degradation
rates of cells at various days after adipogenesis induction with
minimal interference from cell-to-cell variability. Second, fluores-
cent insulin signals were collected from 20 representative cells at 1-
hour time intervals for 8 hours. Average insulin fluorescent
intensity and the distribution across 20 cells were plotted as a
function of time after labeled insulin addition (Fig. 5D). We
avoided measurements within the same cells to minimize photo-
bleaching of insulin signal caused by repeated exposure to laser
beams.
We found strong correlations between insulin degradation rates
and days after adipogenesis induction. In lipid-rich cells, insulin
degradation could be fitted with a first-order decay function
(Fig. 5D); whereas, in lipid-poor cells, insulin degradation could
be described with a linear decay function (Fig. 5D). Decay
constant values for lipid-rich cells increased as a function of days
after adipogenesis induction (Fig. 5E). On the contrary, decay
constant values for lipid-poor cells decreased as a function of days
after adipogenesis induction (Fig. 5E). With regards to the ability
to uptake insulin, we observed a slightly higher average insulin
uptake signal in lipid-rich cells as compared to lipid-poor cells
using flow cytometry analysis (Fig. 5F and Fig. S5A). This data is
consistent with previous report of increased surface insulin
receptors in differentiated 3T3-L1 cells [33]. Taken together,
these observations further support our hypothesis of faster insulin
degradation rates in lipid-rich cells as compared to lipid-poor cells.
Increased kinase activity and glucose import in lipid-rich
cells
Next, we examined the activity of downstream targets of an
insulin signaling cascade. To evaluate insulin-stimulated kinase
signaling activity, we measured the activation of phosphoinositide
3-kinase (PI3K) which is an immediately downstream target of
insulin receptor substrate 1 (IRS-1) [25]. Using an ELISA-based
assay to detect activation of receptor tyrosine kinase, we found
approximately 20-fold increase of kinase activity in the lipid-rich
cell population after insulin addition (Fig. 6A). However, a mere
two-fold increase in kinase activity was observed in the lipid-poor
cell population (Fig. 6A). This observation shows that lipid-poor
cells exhibit a 10-fold reduction in kinase activity as compared to
lipid-rich cells.
We further examined the activity of insulin-stimulated glucose
import in 3T3-L1 cells. Using a fluorescent glucose analog [34],
we analyzed imported glucose signal in lipid-rich and lipid-poor
cells at day 8 using flow cytometry. On average, lipid-rich cells
exhibited two-fold increase in fluorescent glucose analog uptake as
compared to lipid-poor cells (Fig. 6B and Fig. S5B). Flow
cytometry data was further supported by imaging data where
strong and weak cytoplasmic fluorescent glucose analogs were
observed in lipid-rich and lipid-poor cells, respectively (Fig. 6C,
D). This observation suggests that increased kinase activity
positively affects glucose import in lipid-rich cells. Increased
Figure 4. Insensitivity to new insulin stimulation in lipid-poor cells. (A) Absence and (B) presence of insulin-Cy3 signal in lipid-rich and lipid-
poor cells, respectively. Cells were treated with insulin-Cy3 on day 2 and images taken on day 4. (C) Flow cytometry analysis of insulin-Cy3 signal in
lipid-rich (red) and lipid-poor cells (grey) of cell samples presented in (A) and (B). 4lr and 4lp represent sorted lipid-rich and lipid-poor populations at
day 4 after adipogenesis induction, respectively. (D) Quantitative analysis of insulin-Cy3 signal in lipid-rich (lr) and lipid-poor (lp) sorted cell
populations at different days after adipogenesis induction. Insulin-Cy3 was added every 2 days to cell cultures until day 4 and day 6 for analysis on
day 6 and day 8, respectively. Error bars represent distribution across 4 repeated experiments. Two thousand cells were evaluated with flow
cytometry for each experiment. (E) Lipid-poor cells exhibit insulin resistance, whereas (F) lipid-rich cells exhibit insulin sensitivity to additional insulin
stimulation. Cells were treated with unlabeled insulin on day 2, then with insulin-Cy3 on day 4 for 5 minutes before imaging. (G) Flow cytometry
analysis of insulin-Cy3 signal in lipid-rich (red) and lipid-poor cells (grey) of cell samples presented in (E) and (F). (H) Quantitative analysis of insulin-
Cy3 signal in lipid-rich (lr) and lipid-poor (lp) sorted cell populations at different days after adipogenesis induction. Cells were treated with unlabeled
insulin every 2 days until the day of analysis, when insulin-Cy3 was added for 5 minutes before imaging. Error bars represent distribution across 4
repeated experiments. Two thousand cells were evaluated with flow cytometry for each experiment.
doi:10.1371/journal.pone.0005189.g004
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glycolysis product, acetyl-CoA, which serves as a substrate for de
novo lipid synthesis [35]. It is conceivable that the combined effects
of increased insulin sensitivity, increased kinase activity, and
increased glucose import would exponentially increase the rates of
lipid droplet accumulation in lipid-rich cells.
Increased expression of insulin degradation enzyme in
lipid-rich cells
From existing literatures, insulin degradation is controlled in
part by insulin degradation enzyme (IDE) [32]. To investigate the
role of IDE on the kinetics of insulin degradation of differentiating
3T3-L1 cells, we analyzed the expression of IDE using immuno-
fluorescent labeling. Both imaging and flow cytometry analyses
revealed a significantly higher level of IDE expression in lipid-rich
as compared to lipid-poor cells (Fig. 7A–D). Increased IDE
expression in lipid-rich cells was observed after insulin addition on
day 2, which suggests a possible insulin-stimulated expression.
Indeed, current literatures support the dependence of IDE
expression on insulin signaling cascade and more specifically on
the activity of Akt kinase [36]. To establish the dependence of
insulin degradation on IDE, we treated undifferentiated 3T3-L1
cells with an IDE inhibitor, bacitracin, and measure insulin
degradation rates [37]. We found reduced insulin degradation
rates with increasing concentrations of bacitracin (Fig. 7E). We
further evaluated the impact of inhibiting insulin degradation on
fat cell differentiation by adding bacitracin to differentiating 3T3-
L1 cell cultures. We observed drastic inhibitions of lipid droplet
formation with bacitracin treatments (Fig. 7F). However,
bacitracin addition, even at high concentrations, did not
completely inhibit insulin degradation or lipid droplet formation
(Fig. 7E, F). This observation is consistent with previous reports
where multiple insulin processing pathways are found [37].
Furthermore, lipid droplet formation is dependent on more
factors than insulin degradation [3]. Indeed, Temple et al. reported
that lipid droplet formation can also be suppressed in the presence
of pyruvate, which serves as the extracellular energy source,
despite the expression of adipogenic genes [38]. Insulin-stimulated
phosphorylation of Akt was unaffected, which suggests that Akt-
mediated downstream events including expression of IDE were
unaffected. However, addition of glucose restored lipid droplet
formation activity. Together, Temple et al. provided complemen-
tary evidence to our observation that adipogenic gene expression is
insufficient to drive lipid droplet formation. Temple et al. showed
Figure 5. Increased insulin degradation rate in lipid-rich cells. (A) Insulin uptake in both lipid-rich and lipid-poor cells at 5 minutes after
insulin-Cy3 addition. (B) Insulin signal degrades faster in cells with more lipid droplet accumulation at 4 hours after insulin-Cy3 addition. (C) Insulin
signal is undetectable in lipid-rich cells at 6 hours after insulin-Cy3 addition. (A–C) Cells on day 6, or 2 days after removal of unlabeled insulin, are
used. (D) Quantitative analysis of insulin signal degradation in representative cells at various days after induction. Error bars represent distribution of
insulin signal across 20 representative cells analyzed. (E) Decay constant extracted from (D) is plotted as a function of time after induction. (F) Flow
cytometry analysis shows increase in insulin uptake of lipid-rich cells (red) as compared to lipid-poor cells (grey) at day 8 after induction. Red: TPEF
insulin-Cy3 signal. Grey: CARS lipid signal.
doi:10.1371/journal.pone.0005189.g005
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formation activity. Additionally, our data clearly indicate the
importance of insulin degradation in lipid droplet formation.
Rapid insulin degradation could enable recycling of surface insulin
receptors leading to increased sensitivity to new source of insulin
stimulation in lipid-rich cells (Fig. 4D–F) [32].
Prolonged insulin stimulation leads to complete
differentiation of cell cultures
We further proved the significance of insulin signaling by
examining the effects of insulin stimulation on cytoplasmic lipid
droplet formation. First, by keeping IBMX and dexamethasone
input stimulations constant from day 0 to day 2, we varied the
concentrations of insulin in cell cultures from day 2 to day 4.
Quantitative analysis revealed a direct correlation of lipid droplet
formation on insulin stimulation at low insulin concentration from
1 mg/ml to 20 mg/ml (Fig. 8A, B, D). Inhibition of lipid droplet
formation was observed at 50 mg/ml or higher insulin concentra-
tions (Fig. 8C, D). Second, we prolonged insulin stimulation by
replenishing differentiating cell cultures with new source of insulin
at two-day intervals. We observed 100% of cells with lipid droplet
accumulation could be accomplished with prolonged insulin
stimulation at 14 days after adipogenesis induction (Fig. 8E, F).
To show that continued insulin stimulation, by itself, is sufficient
for lipid droplet accumulation, we added 10 mg/ml insulin to
sorted lipid-poor cell populations at day 8 (Fig. 8G). We observed
that all lipid-poor cells eventually accumulate lipid droplets on day
14 (Fig. 8H). Taken together, our data clearly show the
dependence of cytoplasmic lipid droplet accumulation on insulin
stimulation. By varying insulin concentration and duration of
stimulation, the number of lipid-rich cells within differentiating
populations can be reliably produced.
Discussion
It has been proposed that the degree of complexity among
organisms is not correlated with the number of encoded genes, but
with the regulation of gene expression and protein network
interaction [39]. In fact, many important processes including cell-
fate determination and embryonic development are regulated by
spatial-temporal interactions of DNA, RNA, protein, and other
small molecules [40]. Fluctuations in the concentration of
regulatory molecules can be used to select differentiation pathways
[7,41]. Moreover, cell-to-cell variability can be used to improve
evolvability of a population [7,42]. To investigate non-genetic
Figure 6. Increased kinase activity and glucose import in lipid-rich cells. (A) PI3K kinase activity of undifferentiated cells is significantly
lower than differentiated cells. 8lr and 8lp represent sorted lipid-rich and lipid-poor cell populations at day 8 after adipogenesis induction,
respectively. Error bars represent distribution across 4 repeated experiments. (B) Flow cytometry analysis of the import of a fluorescent glucose
analog in a population of cells at day 8. Lipid-rich cells (red) exhibit approximately 2-fold higher in fluorescent glucose intensity than lipid-poor cells
(grey). Imaging reveals strong glucose import in lipid-rich cells (C) as compared to lipid-poor cells (D). (C, D) Cells at day 6 are used for imaging. Scale
bars: 25 mm.
doi:10.1371/journal.pone.0005189.g006
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are required to study in real time the dynamics of gene and protein
network interaction [5,9].
Here, we combine the multimodality imaging capability of a
CARS microscope with the versatility of fluorescent proteins [43]
and fluorescently labeled molecules to examine simultaneously
multiple cellular events within a single cell. Using phenotypic
transformation of 3T3-L1 cells into fat cells as a model system,
adipogenic gene expression, insulin signaling, and glucose import
are visualized simultaneously with lipid droplet accumulation.
Flow cytometry further provides quantitative single-cell analysis in
a high-throughput manner. We find that phenotypic variability
among differentiating 3T3-L1 cells is dependent on the kinetics of
an insulin signaling cascade. Expressions of early-stage and late-
stage adipogenic marker genes strongly suggest that all cells in a
differentiating 3T3-L1 cell culture are committed to fat cell
differentiation (Fig. 2B & Fig. 3). However, differentiating cells
exhibit tremendous cell-to-cell variability on insulin sensitivity,
kinase activity, glucose import, and expression of an insulin
degradation enzyme (Fig. 4–Fig. 7, Fig. S6). It is important to
point out that these variables are part of an insulin signaling
cascade (Fig. 1A) [44]. Increased insulin sensitivity in lipid-rich
cells is associated with increased kinase activity, glucose import,
and insulin degradation. The combinatorial effect could conceiv-
ably amplify subtle variability in insulin signal processing into
drastic variation in the degree of cytoplasmic lipid droplet
accumulation. Indeed, increase concentration and duration of
insulin stimulation are positively correlated with the number of
cells with cytoplasmic lipid droplet accumulation (Fig. 8). The
observed dependence of lipid droplet accumulation on the kinetics
of an insulin signaling cascade is also consistent with many
previous studies where heterogeneous kinase activities are reported
in differentiating 3T3-L1 cells [45] and where increased insulin-
like growth factor overcome Pref-1 mediated inhibition of
adipocyte differentiation [46]. Many recent studies on prokaryotic
cells identify stochastic expression or activity of a single protein as
the cause of phenotypic and behavioural variability [5,7,9,10]. It is
conceivable that stochasticity of an insulin signaling cascade could
contribute to the variability of lipid droplet formation during
adipogenesis. Future studies of insulin signaling pathway could
potentially identify specific events or molecules which control the
rate of lipid droplet formation. Such insights should advance our
understanding of the molecular control of adipogenesis and enable
better drug design to interfere with adipogenesis.
As endocrine organs whose secreted adipokines influence whole
body physiology and metabolism, adipose tissues have become a
major drug target for obesity treatment [2,3]. However,
heterogeneity in adipogenesis interferes with the efficacy of drugs
aiming at adipocyte differentiation. Understanding the source of
cell-to-cell variability during adipogenesis should improve drug
Figure 7. Increased expression of insulin degradation enzyme in lipid-rich cells. (A) TPEF imaging of fluorescent immuno-labeled insulin
degradation enzyme in cells at day 8. (B) Overlay of TPEF imaging of IDE and CARS imaging of lipids. (C) Flow cytometry analysis of IDE expression
level of lipid-rich cells (red) and lipid-poor cells (grey) at day 8. (D) Quantitative flow cytometry analysis of IDE expression level as a function of days
after induction. lr and lp represent lipid-rich and lipid-poor cells at given days after induction. Error bars represent distribution across 4 repeated
experiments. (E) Insulin signal decay as a function of bacitracin concentration. Undifferentiated cells at day 0 are used. (F) Percentage of cell
differentiation as a function of bacitracin concentration. Error bars represent distribution across 4 repeated experiments.
doi:10.1371/journal.pone.0005189.g007
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described in this paper and elsewhere [47] should provide a rapid
means to directly evaluate specific effects of drug on adipogenic
gene expression and insulin signaling pathway. Furthermore, high
penetration depth and three-dimensional sectioning capability
intrinsic to CARS microscopy have allowed its application to tissue
and live animal imaging [13]. Thus, single-cell studies of
heterogeneity in drug-inducible adipogenesis in 3T3-L1 cells in
cultures could be readily translated to single-cell studies of
heterogeneity in adipogenesis of implanted cells in live animals
[48,49]. Finally, signaling cascade is a common gateway for
intracellular signaling pathways [50,51]. Variability in the cascade
of responses could divide a genetically identical cell population
into phenotypically heterogeneous populations with varying rates
of growth, proliferation, survival, and motility [51]. It is
conceivable that the single-cell molecular profiling approach
described in this paper can be applied to study variability of
signaling cascades in diseases to uncover dynamic properties
inaccessible to population measurements.
Materials and Methods
A multimodal CARS microscope
A multimodal microscope which allows CARS and TPEF
imaging on the same platform has been previously described [23].
For forward CARS imaging of lipids, the wave number difference
between pump laser and Stokes laser is tuned to 2840 cm
21 which
matched the Raman shift of symmetric CH2 stretch vibration. For
TPEF imaging of fluorescent molecules, back reflected signal was
collected by the same objective, spectrally separated from the
excitation source, transmitted through appropriate bandpass
filters, and detected by a photomultiplier tube (PMT, H7422-40,
Hamamatsu, Japan) mounted at the back port of the microscope.
Bandpass filters 520/40 nm and 600/65 nm (Chroma Technol-
ogies, Rockingham, VT) were used to transmit TPEF signals from
GFP and RFP or Cy3, respectively. To remove epi-reflected
CARS signals from TPEF signals of Cy3 and RFP, the timing of
the pump and Stokes lasers are desynchronized. Acquisition time
for each image was 1.12 s. Images were analyzed using FluoView
software (Olympus, Center Valley, PA).
Inducing adipogenesis in 3T3-L1 cells
Adipogenesis was induced using an adipogenesis assay kit (Cat.
No. ECM 950, Chemicon International, Temecula, CA). 3T3-L1
cells were grown to confluence in DMEM media consisting of
25 mM of glucose supplemented with 10% calf serum and
penicillin/streptomycin. On day 0, cells were induced with
initiation media (0.5 mM IBMX and 1 mM dexamethasone in
DMEM media supplemented with 10% fetal calf serum and
penicillin (100 units/ml)/streptomycin (100 mg/ml). On day 2,
initiation media was replaced with progression media (10 mg/ml
insulin in DMEM media supplemented with 10% fetal calf serum
and penicillin/streptomycin). On day 4, progression media was
replaced with maintenance media (DMEM supplemented with
10% fetal calf serum and penicillin/streptomycin). From day 4 to
day 8, cells were kept in maintenance media with new
maintenance media being replaced by every two days. Cells are
incubated at 37uC with 5% CO2 at all time.
Figure 8. Lipid droplet accumulation as a function of insulin stimulation. Percentage differentiation of cells stimulated with (A)1mg/ml, (B)
10 mg/ml, and (C) 100 mg/ml insulin. Percentage differentiation is defined as the fraction of cells with cytoplasmic lipid droplet in a differentiating
population. (D) Percentage differentiation as a function of insulin concentration. Error bars represent distribution across 4 repeated assays. (A–D)
Cells are first treated with a constant standard concentration of IBMX/Dex mixture, then with varying insulin concentration and evaluate for
percentage differentiation on day 8. (E) Percentage differentiation evaluated on day 8 and day 14 for cell populations stimulated with 10 mg/ml
insulin from day 2 to day 4 (left 2 columns), and for cell population stimulated with 10 mg/ml insulin continuously (right 2 columns). (F) CARS image
of a cell population stimulated with 10 mg/ml insulin continuously at day 14. (G) CARS image of a sorted lipid-poor cell population on day 8. (H) Lipid
accumulation is observed on day 14, 6 days after sorting, in lipid-poor cell population with continuous 10 mg/ml insulin stimulation. Scale bars of
150 mm for panels A, B, C, F and 25 mm for panels G and H.
doi:10.1371/journal.pone.0005189.g008
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Total RNA was extracted using RNAqueous kit (Cat.
No. AM1912, Ambion, Austin, Texas). A RT
2 SYBR Green
qPCR Master Mix (Cat. No. PA-011, SABiosciences, Frederick,
MD) was employed. Real-time PCR was performed using the iQ5
real-time PCR detection system (BioRad, Hercules, CA) according
to SABiosciences suggested protocol. Forward and reverse primers
for PPARc, Pref-1, aP2, C/EBPa, LP2, and a house-keeping gene
acidic ribosomal phosphoprotein OP were purchased from
Integrated DNA Technologies (Coralville, IA) using previously
published sequences [52].
A dual-reporter plasmid to study Pref-1 and PPARc gene
expression
A ,2 kb DNA fragment was generated by total synthesis
(Genscript, Piscataway, NJ) and cloned into a pDSRed-Express-DR
plasmid (Cat. No. 632423, Clontech,MountainView, CA)between
restriction sites XhoI and BamHI. ThisDNA fragment comprises: a
0.6 kb fragment of PPARc promoter (nucleotides 2603 to +62)
controlling the expression of a destabilized variant of green
fluorescentprotein(0.8 kb), a SV40 polyAtranscriptiontermination
signal (0.25 kb), and a 0.2 kb fragment of Pref-1 promoter
(nucleotides 2183 to +25). The excitation and emission maxima
for green fluorescent protein are 496 nm and 506 nm, and for red
fluorescent protein are 557 nm and 579 nm, respectively.
Stable transfection of 3T3-L1 cells
3T3-L1 cells at density of 1610
5 in 35 mm culture dishes were
transfected with plasmid DNA using FugeneH6 transfection
reagent (Cat. No. 11815091001, Roche Diagnostics, Indianapolis,
IN) at the ratio of 6 ml of FugeneH6 reagent to 1 mg DNA. At
24 hours after transfection, cells were selected with 400 ng/ml
GeneticinH G418 Sulfate (Cat. No. 10131, Invitrogen, Carlsbad,
CA) until individual colonies were observed under a microscope.
Colonies were detached from culture dishes by incubation with
non-enzymatic cell dissociation reagent (Cat. No. 1676949, MP
Biomedicals, Solon, OH) for 5 minutes at 37uC. Individual
colonies were carefully removed using pipette tips under a
microscope. To ensure a single clone is used, a selected colony
was diluted into multi-well plates at the concentration of one cell
per well and re-grown in 100 ng/ml GeneticinH G418 Sulfate
(Cat. No. 10131, Invitrogen, Carlsbad, CA).
Insulin imaging assay
Insulin-Cy3 (Cat. No. FC303506, Phoenix Pharmaceuticals,
Burlingame, CA) was used for all imaging experiments.
PI3K activity assay
PI3K assay was performed using a PI3K assay kit according to
manufacturer’s protocol (Cat. No. EK 2010, Panomics, Redwood
City, CA).
Fluorescent glucose analog import assay
0.3 mM of fluorescent glucose analog (Cat. No. N23106,
Invitrogen, Carlsbad, CA) in glucose-free media was added to
differentiating cell cultures for 1 minute. Cell cultures were
thoroughly washed to remove all exogenous fluorescent glucose
analog, then imaged for intracellular fluorescent signal or analyzed
with flow cytometry.
Flow cytometry sorting and analysis. Cell sorting
An EPICS ALTRA flow cytometer was used to sort differen-
tiating 3T3-L1 cells (Beckman-Coulter, Fullerton, CA). Cells were
dissociated from culture vessels with pre-warmed cell dissociation
solution, passed through a 60 mm filter, and subjected to flow
cytometry sorting. Lipid-poor cells were defined as those with side
scattering signals below 200. Lipid-rich cells were those with side
scattering signals above 200. Sorted cells were collected in
supplemented DMEM media and subjected to real-time PCR
gene expression profiling or kinase activity assay. Insulin-FITC
(Cat. No. I2383, Sigma Aldrich, St Louis, MO) was used instead
of insulin-Cy3 due to the availability of the 488 nm excitation laser
source of the cytometer. No difference in cell response to labelled
insulin sources was observed.
IDE immuno-labeling
Rabbit polyclonal primary antibodies to IDE (Cat.
No. AB25970, Abcam, Cambridge, MA) and goat polyclonal to
rabbit IgG conjugated to FITC secondary antibodies (Cat.
No. AB6717, Abcam, Cambridge, MA) were used according to
manufacturer’s protocols.
Supporting Information
Figure S1 3T3-L1 cell percentage differentiation as a function of
cell source and cell passage number. 3T3-L1 cell lines are obtained
from American Type Culture Collection (ATCC) and from 3
different research labs. Cells at passage 2 are used to evaluate
percentage differentiation among difference cell sources. ATCC
cells are also evaluated at different cell passage number. In all
experiments, post-confluence cells are first treated with a mixture
of 0.5 mM IBMX and 1 mM dexamethasone from day 0 to day 2.
Then 10 mg/ml of insulin are added from day 2 to day 4.
Percentage differentiation is evaluated on day 8 after adipogenesis
induction. Percentage differentiation is calculated based on the
number of lipid-rich cells in a differentiating population identified
with CARS microscopy.
Found at: doi:10.1371/journal.pone.0005189.s001 (0.23 MB TIF)
Figure S2 Flow cytometry sorted cell populations. An EPICS
ALTRA flow cytometer was used to sort differentiating 3T3-L1
cells (Beckman-Coulter, Fullerton, CA). Cells are dissociated from
culture vessels with pre-warmed cell dissociation solution, passed
through a 60 mm filter, and subjected to flow cytometry sorting.
Lipid-poor cells are defined as those with side scattering signals
below 200. Lipid-rich cells are those with side scattering signals
above 200. Sorted cells are collected in supplemented DMEM
media. Images acquired with CARS microscopy.
Found at: doi:10.1371/journal.pone.0005189.s002 (0.42 MB TIF)
Figure S3 Evaluating the effect of a PPARc agonist, rosiglita-
zone, on cell differentiation. (A–D) CARS image of cell cultures
treated with varying concentrations of rosiglitazone. (E) Quanti-
tative analysis of percentage differentiation as a function of
rosiglitazone concentration. Error bars represent distribution
across 4 repeated experiments. Rosiglitazone addition appears to
have no impact on the percentage of 3T3-L1 cells with
cytoplasmic lipid droplet accumulation.
Found at: doi:10.1371/journal.pone.0005189.s003 (1.77 MB TIF)
Figure S4 Competitive cellular uptake of labeled insulin and
glucose analog. (A) Competitive binding of labeled insulin versus
unlabeled insulin. Undifferentiated cells at day 0 are first treated
with varying concentration of unlabeled insulin for 5 minutes,
then treated with labeled insulin at 10 mg/ml for 5 minutes and
subjected to flow cytometry analysis. (B) Competitive cellular
uptake of fluorescent glucose analog versus glucose. Undifferen-
tiated cells at day 0 are first treated with varying concentration of
glucose for 5 minutes, then treated with fluorescent glucose analog
Single-Cell Profiling
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Average fluorescence intensities of 2000 cells at each concentration
are presented. Error bars represent distribution across 4 repeated
experiments.
Found at: doi:10.1371/journal.pone.0005189.s004 (0.20 MB TIF)
Figure S5 Insulin binding and glucose analog uptake as
functions of days after induction. (A) Labeled insulin binding as
a function of days after induction. 3T3-L1 cells at specified days
are treated with 10 ug/ml of labeled insulin for 5 minutes and
subjected to flow cytometry analysis. (B) Fluorescent glucose
analog uptake as a function of days after induction. 3T3-L1 cells at
specified days are first washed with glucose-free media for 2 hours,
then treated with 0.3 mM of fluorescent glucose analog for
1 minute and subjected to flow cytometry analysis. Average
fluorescence intensities of 2000 cells at each specified day are
presented. Error bars represent distribution across 4 repeated
experiments. On the x-axis, 4lp, 6lp, and 8lp represent lipid-poor
cell populations sorted with flow cytometry on day 4, day 6, and
day 8, respectively. On the x-axis, 4lr, 6lr and 8lr represent lipid-
rich cell populations sorted with flow cytometry on day 4, day 6,
and day 8, respectively.
Found at: doi:10.1371/journal.pone.0005189.s005 (0.24 MB TIF)
Figure S6 Lipid droplets formation as a function of PPARc gene
activity, insulin uptake, and glucose import. Y-axis reports single-
cell flow cytometry analysis of lipid droplets formation, or side
scatterings due to cytoplasmic granularity. X-axis reports fluores-
cence intensity of dsGFP, insulin-Cy3, and glucose analog-FITC
which reports PPARc gene activity, insulin uptake, and glucose
import, respectively. Cells are analyzed at day 8 after adipogenesis
induction. Lipid-rich cells exhibit a lack of correlation between
PPARc gene activity and lipid droplet formation, but strong
correlations between lipid droplet formation, insulin uptake, and
glucose import.
Found at: doi:10.1371/journal.pone.0005189.s006 (0.74 MB TIF)
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